Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;23(6):1163-1166.
doi: 10.1038/s41436-021-01111-2. Epub 2021 Feb 18.

Preferences of biobank participants for receiving actionable genomic test results: results of a recontacting study

Nora B Henrikson  1 , Aaron Scrol  2 , Kathleen A Leppig  2 , James D Ralston  2 , Eric B Larson  2 , Gail P Jarvik  3
Affiliations

Preferences of biobank participants for receiving actionable genomic test results: results of a recontacting study

Nora B Henrikson et al. Genet Med. 2021 Jun.

Abstract

Purpose: We sought to determine preferences of biobank participants whose samples were tested for clinically actionable variants but did not respond to an initial invitation to receive results.

Methods: We recontacted a subsample of participants in the Kaiser Permanente Washington/University of Washington site of the Electronic Medical Records and Genomics (eMERGE3) Network. The subsample had provided broad consent for their samples to be used for research but had not responded to one initial mailed invitation to receive their results. We sent a letter from the principal investigators with phone outreach. If no contact was made, we sent a certified letter stating our assumption that participant had actively refused. We collected reasons for declining.

Results: We recontacted 123 participants. Response rate was 70.7% (n = 87). Of these, 62 (71.3%) declined the offer of returned results and 25 (28.7%) consented. The most common reasons provided for refusal included not wanting to know (n = 22) and concerns about insurability (n = 28).

Conclusion: Efforts to recontact biobank participants can yield high response. Though active refusal upon recontact was common, our data do not support assuming initial nonresponse to be refusal. Future research can work toward best practices for reconsenting, especially when clinically actionable results are possible.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST NOTIFICATION PAGE

The authors have no conflicts to declare.

Figures

Figure 1.
Figure 1.. Study overview
See this image and copyright information in PMC

References

    1. McCarty CA, Chisholm RL, Chute CG, et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics. 2011;4:13. - PMC - PubMed
    1. eMERGE Consortium. Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network. Am J Hum Genet. 2019;105(3):588–605. - PMC - PubMed
    1. Ludman EJ, Fullerton SM, Spangler L, et al. Glad you asked: participants’ opinions of re-consent for dbGap data submission. J Empir Res Hum Res Ethics. 2010;5(3):9–16. - PMC - PubMed
    1. Trinidad SB, Fullerton SM, Bares JM, Jarvik GP, Larson EB, Burke W. Informed consent in genome-scale research: What do prospective participants think? AJOB Prim Res. 2012;3(3):3–11. - PMC - PubMed
    1. Green RC, Berg JS, Grody WW, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15(7):565–574. - PMC - PubMed

Publication types

LinkOut - more resources